ACROBiosystems/Hepacivirus C E2 Protein, His Tag/1mg/E2P

价格
面议
货号:E2P
浏览量:127
品牌:ACROBiosystems
服务
全国联保
正品保证
正规发票
签订合同
商品描述
This product is still under development. Please contact us if you have interest in this product. We will accelerate the development process accordingly and reserve this product for you as request.
  • Synonym
    E2
  • Source
    Hepacivirus C E2, His Tag (E2P-C52H7) is expressed from human 293 cells (HEK293). It contains AA Ala 1 - Cys 190 (Accession # Q0N1H1-1).
    Predicted N-terminus: Ala 1
  • Molecular Characterization
    Online-Res(Ala 1 - Cys 190) Q0N1H1-1

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 22.6 kDa.

  • Endotoxin
  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • Background
    Glycoprotein E2 is an approximately 50 kDa viral envelope protein encoded by the hepatitis C virus (HCV) genome. HCV infection often progresses to severe, liver-associated diseases, such as cirrhosis, steatosis, and hepatocellular carcinoma. Both E1 and E2 are essential for infectivity, with E2 possessing the binding sites for the entry receptors CD81 and SCARB1.Moreover, glycoprotein E2 is BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.
  • References
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

ACROBiosystems治疗性抗体的功效不仅取决于Fab片段及其与靶抗原的结合活性,还取决于Fc片段及其与关键Fc受体的相互作用。Fc片段对FcRn的结合亲和力(FCGRT&B2M)将预测抗体的半衰期,而Fc片段与FcγRIIIa(CD16a)之间的结合亲和力将影响抗体引发ADCC的能力(抗体依赖性细胞介导的细胞毒性)。因此,必须在抗体工程化过程中针对一组受体测试候选人。ACROBiosystems提供了完整的重组Fc受体蛋白集合,包括它们的常见变体,以帮助您加快mAb的开发。